BIORESTORATIVE THERAPIES ($BRTX) posted quarterly earnings results on Tuesday, August 12th. The company reported earnings of -$0.30 per share, beating estimates of -$0.39 by $0.09. The company also reported revenue of $303,000, missing estimates of $346,800 by $-43,800.
You can see Quiver Quantitative's $BRTX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
BIORESTORATIVE THERAPIES Hedge Fund Activity
We have seen 7 institutional investors add shares of BIORESTORATIVE THERAPIES stock to their portfolio, and 3 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CITADEL ADVISORS LLC removed 21,481 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $38,236
- VIRTU FINANCIAL LLC added 12,032 shares (+inf%) to their portfolio in Q2 2025, for an estimated $20,040
- MORGAN STANLEY added 10,500 shares (+38.2%) to their portfolio in Q1 2025, for an estimated $18,690
- UBS GROUP AG removed 7,951 shares (-48.8%) from their portfolio in Q1 2025, for an estimated $14,152
- GEODE CAPITAL MANAGEMENT, LLC removed 5,735 shares (-9.6%) from their portfolio in Q2 2025, for an estimated $9,552
- TOWER RESEARCH CAPITAL LLC (TRC) added 1,620 shares (+102.7%) to their portfolio in Q1 2025, for an estimated $2,883
- STONEX GROUP INC. added 1,092 shares (+2.2%) to their portfolio in Q1 2025, for an estimated $1,943
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
